Loblaw Companies Limited · TSX:L
Loblaw Companies — Q2 2017 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, Jul 26, 2017
Slide 1: Q2 2017 Supplementary Slides
Q2 2017 Supplementary Slides July 26, 2017 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics Q2 - Consolidated
Key Financial Metrics Q2 Consolidated 2017 Margin/Growth B/(W) Consolidated Revenue $ 11,079M +3.2% Adjusted EBITDA and Margin $ 985M 8.9% +30bps Adjusted Diluted Net Earnings Per Common $ 1.11 +9.9% Share Free Cash Flow $ 547M (2016 $432M) Capex $ 254M (2016 $214M) 3
Slide 4: Key Financial Metrics Q2 - Retail Segment
Key Financial Metrics Q2 Retail Segment 2017 Margin/Growth B/(W) Total Retail Revenue $ 10,827M +3.2% Retail Revenue - Food Retail $ 7,944M +2.9% Retail Revenue - Drug Retail $ 2,883M +3.9% $ 2,847M 26.7% +30bps Retail Adjusted Gross Profit and Margin (excluding the impact of the consolidation of fr
Slide 5: Key Operational Metrics Q2 - Food Retail (Loblaw)
Key Operational Metrics Q2 Food Retail (Loblaw) 2017 Food Retail SSS Growth ex gas bar Relatively flat (excluding the estimated impact of the timing of Easter) (Including the impact of Easter, SSS growth was 1.0%) Basket Size Traffic Loblaw Food Price Index was marginally higher than CPI of -1.4% In
Slide 6: Key Operational Metrics Q2 - Drug Retail (Shoppers Drug Mart)
Key Operational Metrics Q2 Drug Retail (Shoppers Drug Mart) 2017 Pharmacy Sales $ 1,377M +4.0% +3.5% Pharmacy SSS (Including the unfavourable impact of Easter, due to the statutory holiday, (excluding the estimated impact of the timing of Easter) Pharmacy SSS was 2.9%.) # Rx Dispensed (Rx Count) Abs